York, PA - November 22, 2013 - DENTSPLY International Inc.(NASDAQ-XRAY) today announced that it completed one acquisition and has signed an agreement and expects to close a second in the near future. The Company completed the acquisition of QAHR, a direct dental selling organization with headquarters in Hong Kong and operations also in mainland China. DENTSPLY has had a commercial relationship with QAHR since 2000 focused primarily on certain of its key dental implant brands. The Company also announced that it has entered into an agreement to acquire certain assets of Triodent, a New Zealand-based manufacturer of a line of professional dental consumables used in restorative dentistry. Triodent is known for its innovative sectional matrix system.
These two acquisitions represent aggregate annual revenue of approximately $30 million, of which approximately half would be incremental to DENTSPLY given the prior commercial relationship that existed with both companies. Terms of the transactions were not disclosed.
About DENTSPLY International, Inc.
DENTSPLY International Inc. is a leading manufacturer and distributor of dental and other consumable medical device products. The Company believes it is the world's largest manufacturer of consumable dental products for the professional dental market. For over 110 years, DENTSPLY's commitment to innovation and professional collaboration has enhanced its portfolio of branded consumables and small equipment. Headquartered in the United States, the Company has global operations with sales in more than 120 countries. Visit www.dentsply.com for more information about DENTSPLY and its products.
This press release contains forward-looking information (within the meaning of the Private Securities Litigation Reform Act of 1995) regarding future events or the future financial performance of the Company that involve substantial risks and uncertainties. Actual events or results may differ materially from those in the projections or other forward-looking information set forth herein as a result of certain risk factors. These risk factors include, without limitation; the continued strength of dental and medical markets, the timing, success and market reception for our new and existing products, uncertainty with respect to governmental actions with respect to dental and medical products, outcome of litigation and/or governmental enforcement actions, volatility in the capital markets or changes in our credit ratings, continued support of our products by influential dental and medical professionals, our ability to successfully integrate acquisitions, risks associated with foreign currency exchange rates, risks associated with our competitors' introduction of generic or private label products, our ability to accurately predict dealer and customer inventory levels, our ability to successfully realize the benefits of any cost reduction or restructuring efforts, our ability to obtain a supply of certain finished goods and raw materials from third parties and changes in the general economic environment that could affect the business. Changes in such assumptions or factors could produce significantly different results.
For further information contact:
Derek Leckow
Vice President
Investor Relations
(717) 849-7863